The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Blood Cells, Molecules & Diseases

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1079-9796(03)00071-8PMID 12850492
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.

  2001cited by this paper
• Influence of Bilirubin Uridine Diphosphate– Glucuronosyltransferase 1A Promoter Polymorphisms on Serum Bilirubin Levels and Cholelithiasis in Children With Sickle Cell Anemia

  2001cited by this paper
• Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II).

  2000cited by this paper
• Co-inherited Gilbert's syndrome: a factor determining hyperbilirubinemia in homozygous beta-thalassemia.

  1999cited by this paper
• Molecular pathology of Crigler-Najjar type I and II and Gilbert's syndromes.

  1999cited by this paper
• (TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome.

  1999cited by this paper
• Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates.

  1999cited by this paper
• Genetic evidence of an early exit of Homo sapiens sapiens from Africa through eastern Africa

  1999cited by this paper
• Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

  1998cited by this paper
• Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate‐glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese

  1998cited by this paper
• UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan.

  1998cited by this paper
• Ascertainment bias cannot entirely account for human microsatellites being longer than their chimpanzee homologues.

  1998cited by this paper
• Microsatellite diversity and the demographic history of modern humans.

  1997cited by this paper
• Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.

  1997cited by this paper
• The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous β‐thalassaemia and in glucose‐6‐phosphate dehydrogenase deficiency

  1997cited by this paper
• Microsatellite data support an early population expansion in Africa.

  1997cited by this paper
• Hyperbilirubinaemia in heterozygous β‐thalassaemia is related to co‐inherited Gilbert's syndrome

  1997cited by this paper
• UGT1*1 genotyping in a Canadian Inuit population.

  1997cited by this paper
• The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

  1995cited by this paper
• The thalassaemia syndromes

  1965cited by this paper
• CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Coinheritance of Gilbert Syndrome Increases the Risk for Developing Gallstones in Patients With Hereditary Spherocytosis

  year unknowncited by this paper

• Prevalence and Data-Driven Exploration of Pre-Diagnostic Symptoms and Features of Gilbert’s Syndrome in the UK Primary Care Population

  2025cites this paper
• Pharmacogenomics and Personalized Medicine

  2024cites this paper
• UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?

  2024cites this paper
• Genetic variations underlying Gilbert syndrome and HBV infection outcomes: a cross-sectional study

  2023cites this paper
• Novel combined UGT1A1 mutations in Crigler Najjar Syndrome type I

  2022cites this paper
• Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series

  2022cites this paper
• Comprehensive characterization of pharmacogenes in a Taiwanese Han population

  2022cites this paper
• Pharmacogenetics of Drugs Used in the Treatment of Cancers

  2022cites this paper
• Bilirubin: the yellow hormone?

  2021cites this paper
• Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort

  2021cites this paper
• The contribution of genetic factors to hyperbilirubinemia and kernicterus risk in neonates: a targeted update

  2021cites this paper
• A high frequency of Gilbert syndrome (UGT1A1*28/*28) and associated hyperbilirubinemia but not cholelithiasis in adolescent and adult north Indian patients with transfusion-dependent β-thalassemia

  2020cites this paper
• Persistent Hyperbilirubinaemia with Absence of Urinary Bile Salts and Bile Pigments

  2020cites this paper
• Pharmacogenetic impact of UGT1A1 polymorphisms on pulmonary neuroendocrine tumours treated with metronomic irinotecan‐based chemotherapy in Chinese populations

  2020cites this paper
• Genetically raised serum bilirubin levels and lung cancer: a cohort study and Mendelian randomisation using UK Biobank

  2020cites this paper
• Place for elective cholecystectomy for patients with severe thalassaemia: a retrospective case control study

  2019cites this paper
• MEDICAL AND BIOLOGICAL ASPECTS RELATED TO ASSESSMENT OF IMPACTS EXERTED BY RISK FACTORS

  2019cites this paper
• the Prevalence of UGT1A1*93 and ABCC5 Polymorphisms in Cancer Patients Receiving Irinotecan-Based Chemotherapy at Al-Najaf Al-Ashraf

  2019cites this paper
• Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria

  2019influential citation
• Comparison of effects of UGT1A1*6 and UGT1A1*28 on irinotecan-induced adverse reactions in the Japanese population: analysis of the Biobank Japan Project

  2019cites this paper
• Bilirubin as a predictor of diseases of civilization. Is it time to establish decision limits for serum bilirubin concentrations?

  2019cites this paper
• Safety and Effective Biomakers in Oncology

  2019cites this paper
• Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine

  2018cites this paper
• Significance of UGT1A1*28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C

  2018cites this paper
• Prevalence of Gilbert Syndrome in Bangladesh

  2018cites this paper
• UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children

  2018cites this paper
• UGT1A1 (TA)n Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia

  2018cites this paper
• Pharmacogenetic considerations for HIV treatment in different ethnicities: an update

  2017cites this paper
• UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis

  2017cites this paper
• UGT1A1∗28 relationship with abnormal total bilirubin levels in chronic hepatitis C patients

  2017cites this paper
• Distribution of uridine diphosphate glucuronosyltransferase 1A polymorphisms and their role in irinotecan-induced toxicity in patients with cancer

  2017cites this paper
• Gly71Arg UGT1A1 polymorphism is associated with breast cancer susceptibility in Han Chinese women.

  2016cites this paper
• Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis

  2016cites this paper
• Correlation of UGT1A1(*)28 and (*)6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients.

  2016cites this paper
• UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer

  2016cites this paper
• Obstetric Obesity is Associated with Neonatal Hyperbilirubinemia with High Prevalence in Native Hawaiians and Pacific Island Women.

  2016cites this paper
• Concepts of Anticancer Treatment and Pharmacogenomics in Cancer Treatments

  2015cites this paper
• Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10

  2015influential citation
• Interplay of co-inherited diseases can turn benign syndromes in a deadly combination: haemoglobinopathy and bilirubin transport disorder.

  2015cites this paper
• Phase II clinical trial of metronomic chemotherapy with combined irinotecan and tegafur–gimeracil–oteracil potassium in metastatic and recurrent breast cancer

  2015cites this paper
• Relationship between UGT1A1*6/*28 polymorphisms and severe toxicities in Chinese patients with pancreatic or biliary tract cancer treated with irinotecan-containing regimens

  2015cites this paper
• First report of a Japanese phase I study of triplet plus bevacizumab for chemotherapy-naive metastatic colorectal cancer (J1-TRIBE study)

  2015cites this paper
• Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia

  2015cites this paper
• A GWAS Study on Liver Function Test Using eMERGE Network Participants

  2015cites this paper
• Glucuronidation of OTS 167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT 1 A 1 , UGT 1 A 3 , UGT 1 A 8 , and UGT 1 A 10 s

  2015influential citation
• Genetic factors affecting drug disposition in Asian cancer patients

  2015cites this paper
• DMD063271 928..935

  2015influential citation
• Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer

  2014cites this paper
• Do UGT1A1 and HMOX1 gene promoter polymorphisms increase the risk of hyperbilirubinemia and gallstones in patients with hereditary spherocytosis?

  2014cites this paper
• Evaluation of the effect of UGT1A1 polymorphisms on dolutegravir pharmacokinetics.

  2014cites this paper
• Correlation of UGT1A1 TATA-box polymorphism and jaundice in breastfed newborns-early presentation of Gilbert's syndrome

  2014cites this paper
• The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis

  2014cites this paper
• UGT1A1 gene variants and clinical risk factors modulate hyperbilirubinemia risk in newborns

  2014cites this paper
• Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations

  2014cites this paper
• Effect of the global variation of thegenetic biomarker uridine diphosphate glucuronosyl transferase

  2014cites this paper
• Implementation of pharmacogenetics in evidence-based medicine: Toward advancing personalized medicine

  2014cites this paper
• Arşiv Kaynak Tarama Dergisi Archives Medical Review Journal

  2014cites this paper
• Pharmacogenomics and stratified medicine

  2014cites this paper
• Severe neonatal hyperbilirubinemia and UGT1A1 promoter polymorphism.

  2014cites this paper
• Genetic variation underlying common hereditary hyperbilirubinaemia (Gilbert's syndrome) and respiratory health in the 1946 British birth cohort.

  2014cites this paper
• Association between inherited monogenic liver disorders and chronic hepatitis C.

  2014cites this paper
• The Effect of UGT1A1 Promoter Polymorphism in the Development of Hyperbilirubinemia and Cholelithiasis in Hemoglobinopathy Patients

  2013cites this paper
• The role of the inherited disorders of hemoglobin, the first "molecular diseases," in the future of human genetics.

  2013influential citation
• UDP-glucuronosyltransferase 1A1 (UGT1A1) gene haplotypes and their effect on serum bilirubin concentration in healthy Indian adults.

  2013cites this paper
• Association between UGT1A1*28 Polymorphisms and Clinical Outcomes of Irinotecan-Based Chemotherapies in Colorectal Cancer: A Meta-Analysis in Caucasians

  2013cites this paper
• Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians

  2013cites this paper
• Distribution of selected gene polymorphisms of UGT1A1 in a Saudi population

  2013cites this paper
• UGT1A1 (TA)n genotyping in sickle-cell disease: high resolution melting (HRM) curve analysis or direct sequencing, what is the best way?

  2013cites this paper
• Gilbert ’ s Syndrome Gilbert ’ s Sendromu

  2013cites this paper
• Heredity Blood Disorders (HBD): A Scientometric Analysis of Publications Output from India during 2002-2011

  2012cites this paper
• Is there diversity among UGT1A1 polymorphism in Japan?

  2012cites this paper
• Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

  2012cites this paper
• The hemoglobin E thalassemias.

  2012cites this paper
• Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia

  2012cites this paper
• Pharmacogenetics in Cancer

  2012cites this paper
• Genomics and the Developing World

  2012cites this paper
• Polymorphisms in genes involved in the metabolism and transport of soy isoflavones affect the urinary metabolite profile in premenopausal women following consumption of a commercial soy supplement as a single bolus dose.

  2012cites this paper
• Prevalence of UGT1A1 Gene Polymorphism in Patients with Hemolytic Anemia in Southern Brazil

  2011influential citation
• Is Gilbert syndrome a new risk factor for breast cancer?

  2011cites this paper
• Snapback primer genotyping of the Gilbert syndrome UGT1A1 (TA)(n) promoter polymorphism by high-resolution melting.

  2011cites this paper
• Mutation Analysis in Crigler-Najjar Syndrome Type II-Case Report and Literature Review.

  2011cites this paper
• Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy

  2011cites this paper
• Serum bilirubin and risk of respiratory disease and death.

  2011cites this paper
• Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.

  2011cites this paper
• Phase I/II study of FOLFIRI in Japanese patients with advanced colorectal cancer.

  2011cites this paper
• Prevalence of Clinically Relevant UGT1A Alleles and Haplotypes in African Populations

  2011influential citation
• Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer.

  2011cites this paper
• Rapid UGT1A1 (TA)(n) genotyping by high resolution melting curve analysis for Gilbert's syndrome diagnosis.

  2010cites this paper
• Pharmacogenetics in Colorectal Cancer

  2010cites this paper
• The effect of UGT1A1 promoter polymorphism on bilirubin response to hydroxyurea therapy in hemoglobinopathies.

  2010cites this paper
• Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events.

  2010cites this paper
• The clinical application of UGT1A1 pharmacogenetic testing: Gene-environment interactions

  2010influential citation
• Pharmacogenomic Markers for Cancer Therapy

  2010cites this paper
• Pharmacogenetics of irinotecan disposition and toxicity: a review.

  2010cites this paper
• Irinotecan pharmacogenomics.

  2010cites this paper
• UGT1A1 gene polymorphism as a potential factor inducing iron overload in the pathogenesis of type 1 hereditary hemochromatosis

  2009cites this paper
• Disorders of Hemoglobin: THE β THALASSEMIAS

  2009cites this paper
• Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.

  2009cites this paper
• Molecular Markers for Individualized Therapy in Colorectal Cancer: Progress Towards a Pharmacogenomics Array

  2009cites this paper
• UGT1A1 Gene Polymorphisms in North Indian Neonates Presenting with Unconjugated Hyperbilirubinemia

  2009cites this paper